NECTIN4 gene amplification development strategy underway for zelenectide pevedotin in breast cancer, lung cancer and multiple tumors, with several Phase 1/2 trials planned to start in 2025 Emerging ...
NotebookLM is Google’s AI-powered research platform, which will now let users organise information into data tables.
Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at the 2025 ASCO GU meeting. Updated data from studies like EV-302 and ...
76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI first-line therapy Molecular responses continue to deepen with extended treatment duration, reaching 60% ...
The MARIPOSA trial demonstrates that amivantamab plus lazertinib significantly reduces resistance and extends survival in EGFR-mutated NSCLC compared to osimertinib. Dual inhibition of EGFR and MET by ...
The Georgetown Center on Education and the Workforce released an updated data tool today that assesses the return on investment of different higher education institutions. The revised tool includes ...
RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced updated data from the Phase 1/2 STAAR study evaluating isaralgagene ...
Jasper Therapeutics, Inc. announced that it is presenting updated clinical data from its Phase 1b/2a BEACON study on briquilimab, an antibody therapy targeting c-Kit to treat mast cell-driven diseases ...
Celcuity Inc. remains a Strong Buy, driven by positive Phase 3 VIKTORIA-1 data for gedatolisib in 2nd-line PIK3CA wild-type HR+/HER2- advanced breast cancer patients. The company expects to complete a ...
The Federal Bureau of Investigation quietly updated its 2022 crime data to show an increase in violent crimes, despite previous data showing violent crimes had fallen that year, which was touted as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback